These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 32971462)
1. Generation of two human iPSC lines from patients with maturity-onset diabetes of the young type 2 (MODY2) and permanent neonatal diabetes due to mutations in the GCK gene. Aqel YWA; Ali G; Elsayed AK; Al-Khawaga S; Hussain K; Abdelalim EM Stem Cell Res; 2020 Oct; 48():101991. PubMed ID: 32971462 [TBL] [Abstract][Full Text] [Related]
2. Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene. Bennett K; James C; Mutair A; Al-Shaikh H; Sinani A; Hussain K Pediatr Diabetes; 2011 May; 12(3 Pt 1):192-6. PubMed ID: 21518409 [TBL] [Abstract][Full Text] [Related]
3. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs. Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519 [TBL] [Abstract][Full Text] [Related]
4. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Gloyn AL Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946 [TBL] [Abstract][Full Text] [Related]
5. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256 [TBL] [Abstract][Full Text] [Related]
6. Screening of mutations in the GCK gene in Jordanian maturity-onset diabetes of the young type 2 (MODY2) patients. Khalil R; Al-Sheyab F; Khamaiseh E; Halaweh MA; Abder-Rahman HA Genet Mol Res; 2009 May; 8(2):500-6. PubMed ID: 19551638 [TBL] [Abstract][Full Text] [Related]
7. A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program. Inoue M; Sakuraba Y; Motegi H; Kubota N; Toki H; Matsui J; Toyoda Y; Miwa I; Terauchi Y; Kadowaki T; Shigeyama Y; Kasuga M; Adachi T; Fujimoto N; Matsumoto R; Tsuchihashi K; Kagami T; Inoue A; Kaneda H; Ishijima J; Masuya H; Suzuki T; Wakana S; Gondo Y; Minowa O; Shiroishi T; Noda T Hum Mol Genet; 2004 Jun; 13(11):1147-57. PubMed ID: 15102714 [TBL] [Abstract][Full Text] [Related]
8. GCK mutations in Chinese MODY2 patients: a family pedigree report and review of Chinese literature. Ping Xiao Y; Hua Xu X; Lan Fang Y; Jiang L; Chen C; Liang L; Lin Wang C J Pediatr Endocrinol Metab; 2016 Aug; 29(8):959-64. PubMed ID: 27269892 [TBL] [Abstract][Full Text] [Related]
9. Variable presentations of Oza CM; Karguppikar MB; Khadilkar V; Khadilkar A BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35228227 [TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of an induced pluripotent stem cell (iPSC) line SDQLCHi063-A from peripheral blood mononuclear cells of a patient with Maturity-onset diabetes of the young type 2 carrying GCK exon 1 deletion. Gao M; Li X; Lv Y; Yang X; Liu Y; Gai Z Stem Cell Res; 2024 Jun; 77():103389. PubMed ID: 38507882 [TBL] [Abstract][Full Text] [Related]
12. Analysis of mutations in the glucokinase gene in people clinically characterized as MODY2 without a family history of diabetes. Lopez AP; de Dios A; Chiesa I; Perez MS; Frechtel GD Diabetes Res Clin Pract; 2016 Aug; 118():38-43. PubMed ID: 27289208 [TBL] [Abstract][Full Text] [Related]
13. MODY2 caused by a novel mutation of GCK gene. Pulst K; Arbo T; Kahre T; Peet A; Tillmann V J Pediatr Endocrinol Metab; 2012; 25(7-8):801-3. PubMed ID: 23155715 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the GCK gene in 79 MODY type 2 patients: A multicenter Turkish study, mutation profile and description of twenty novel mutations. Aykut A; Karaca E; Onay H; Gökşen D; Çetinkalp Ş; Eren E; Ersoy B; Çakır EP; Büyükinan M; Kara C; Anık A; Kırel B; Özen S; Atik T; Darcan Ş; Özkınay F Gene; 2018 Jan; 641():186-189. PubMed ID: 29056535 [TBL] [Abstract][Full Text] [Related]
15. Glucokinase (GCK) mutations and their characterization in MODY2 children of southern Italy. Capuano M; Garcia-Herrero CM; Tinto N; Carluccio C; Capobianco V; Coto I; Cola A; Iafusco D; Franzese A; Zagari A; Navas MA; Sacchetti L PLoS One; 2012; 7(6):e38906. PubMed ID: 22761713 [TBL] [Abstract][Full Text] [Related]
16. Mutations in GCK May Lead to MODY2 by Reducing Glycogen Synthesis. Li Z; Li K; Sun Y; Jiang X; Liu J; Li J; Fang L; Li G; Guan Q; Xu C Adv Biol (Weinh); 2022 Nov; 6(11):e2200097. PubMed ID: 35770790 [TBL] [Abstract][Full Text] [Related]
17. Glucokinase (GCK) in diabetes: from molecular mechanisms to disease pathogenesis. Abu Aqel Y; Alnesf A; Aigha II; Islam Z; Kolatkar PR; Teo A; Abdelalim EM Cell Mol Biol Lett; 2024 Sep; 29(1):120. PubMed ID: 39245718 [TBL] [Abstract][Full Text] [Related]
18. Clinical follow-up of two Brazilian subjects with glucokinase-MODY (MODY2) with description of a novel mutation. DellaManna T; Silva MR; Chacra AR; Kunii IS; Rolim AL; Furuzawa G; Maciel RM; Reis AF Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):490-5. PubMed ID: 23295287 [TBL] [Abstract][Full Text] [Related]
19. A new compound heterozygosis for inactivating mutations in the glucokinase gene as cause of permanent neonatal diabetes mellitus (PNDM) in double-first cousins. Esquiaveto-Aun AM; De Mello MP; Paulino MF; Minicucci WJ; Guerra-Júnior G; De Lemos-Marini SH Diabetol Metab Syndr; 2015; 7():101. PubMed ID: 26587058 [TBL] [Abstract][Full Text] [Related]
20. A novel pathogenic variant in the glucokinase gene found in two Japanese siblings with maturity-onset diabetes of the young 2. Tanaka S; Akagawa H; Azuma K; Watanabe K; Higuchi S; Iwasaki N Endocr J; 2023 Jun; 70(6):629-634. PubMed ID: 37045781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]